Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Arthritis Rheum ; 40(4): 734-42, 1997 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-9125258

RESUMEN

OBJECTIVE: To examine racial differences in disease onset, extent, manifestations, and survival among women with scleroderma. METHODS: A retrospective cohort study of women with scleroderma, diagnosed in Michigan between 1980 and 1991, was conducted. Clinical, laboratory, and demographic data were abstracted from the patients' medical records. RESULTS: A total of 514 women with scleroderma were identified: 117 (23%) were black and 397 (77%) were white. Among black women, the mean age at diagnosis was lower (44.5 years versus 51.5 years; P < 0.001) and diffuse disease was more common (49.6% versus 24.9%; P < 0.001) than among white women. The overall incidence of scleroderma was 14.1 per million per year: 22.5 per million per year in black women versus 12.8 per million per year in white women (P < 0.001). Pericarditis (P = 0.009), pulmonary hypertension (P < 0.001), pleural effusions (P = 0.01), myositis (P = 0.02), and an erythrocyte sedimentation rate >40 mm/hour (P < 0.001) were more frequent among black women, while white women were more likely to have digital infarctions (P < 0.001). Survival at 7 years from diagnosis was 72.5% among black women and 77.6% among white women. Age-adjusted survival was significantly reduced among black women (P = 0.033), most likely because of increased diffuse involvement. Survival among those with renal or pulmonary involvement was also significantly reduced. CONCLUSION: Black women with scleroderma were significantly more likely than white women to develop diffuse disease, be diagnosed at a younger age, have a higher incidence of inflammatory features, and have a worse age-adjusted survival rate.


Asunto(s)
Población Negra , Esclerodermia Sistémica/etnología , Población Blanca , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Estudios de Casos y Controles , Estudios de Cohortes , Femenino , Humanos , Michigan/epidemiología , Persona de Mediana Edad , Estudios Retrospectivos , Factores de Riesgo , Esclerodermia Sistémica/mortalidad , Análisis de Supervivencia
3.
J Rheumatol ; 22(1): 29-33, 1995 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-7535361

RESUMEN

OBJECTIVE: To determine the feasibility and safety of combining oral 8-methoxypsoralen (8-MOP) and intraarticular ultraviolet A band light (UVA) to treat rheumatoid synovitis, and to demonstrate a favorable biological effect. METHODS: Six patients with rheumatoid arthritis (RA) and clinically evident knee synovitis were given a single oral dose of 8-MOP (0.6 mg/kg) followed by arthroscopy with a UVA laser equipped small arthroscope. Nine tissue samples treated with UVA doses ranging from 4 to 52 J/cm2 were examined by light microscopy and by immunohistochemistry for vascular cell adhesion molecule 1 (VACM-1), intracellular adhesion molecule 1 (ICAM-1), E-selectin and HLA-DR expression. RESULTS: No reduction in inflammation was evident on light microscopy, nor was there any evidence of tissue injury on gross inspection or light microscopy. At 28 and 52 J/cm2, VCAM-1, ICAM-1 and E-selectin staining were reduced in the posttreatment synovial biopsies. No local or systemic complications were observed by Day 30 in any patient. CONCLUSION: This treatment modality appears to be feasible and safe and may potentially be useful in the treatment of the synovitis associated with RA.


Asunto(s)
Artritis Reumatoide/tratamiento farmacológico , Articulación de la Rodilla , Metoxaleno/administración & dosificación , Sinovitis/tratamiento farmacológico , Terapia Ultravioleta , Adulto , Anciano , Artritis Reumatoide/patología , Biopsia , Moléculas de Adhesión Celular/análisis , Selectina E , Estudios de Factibilidad , Femenino , Antígenos HLA-DR/análisis , Humanos , Molécula 1 de Adhesión Intercelular/análisis , Articulación de la Rodilla/patología , Masculino , Metoxaleno/uso terapéutico , Persona de Mediana Edad , Proyectos Piloto , Membrana Sinovial/irrigación sanguínea , Membrana Sinovial/química , Sinovitis/patología , Molécula 1 de Adhesión Celular Vascular
4.
J Clin Invest ; 89(1): 308-14, 1992 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-1345917

RESUMEN

The function of gamma delta T cells is still elusive. The nature of the antigens that they recognize and the mode of presentation of these antigens are largely unknown. The majority of human peripheral gamma delta T cells bear a V gamma 9/V delta 2 T cell receptor, and display nonclonal reactivity to mycobacteria, without restriction by MHC. It is unknown whether these cells have clonal antigenic specificity as well. Here we describe rheumatoid arthritis-derived V gamma 9/V delta 2 T cell clones, displaying dual antigenic recognition: a nonclonal, MHC-unrestricted recognition of mycobacteria, and a clonal recognition of a short tetanus toxin peptide presented by HLA-DRw53, a nonpolymorphic class II MHC molecule associated with susceptibility to rheumatoid arthritis. This is the first evidence that V gamma 9/V delta 2 T cells can recognize nominal antigenic peptides presented by class II MHC molecules. These results suggest that much like alpha beta T cells, V gamma 9/V delta 2 cells may contribute to the immune response against foreign antigens in an antigen-specific and MHC-restricted manner. The reactivity of these gamma delta T cells to mycobacteria may represent a superantigen-like phenomenon.


Asunto(s)
Células Clonales/inmunología , Receptores de Antígenos de Linfocitos T gamma-delta/inmunología , Subgrupos de Linfocitos T/inmunología , Secuencia de Aminoácidos , Células Presentadoras de Antígenos/inmunología , Artritis Reumatoide/inmunología , Linfocitos T CD4-Positivos/inmunología , Antígenos CD8/inmunología , Genes MHC Clase II , Antígenos HLA/inmunología , Humanos , Activación de Linfocitos/inmunología , Complejo Mayor de Histocompatibilidad/inmunología , Datos de Secuencia Molecular , Mycobacterium tuberculosis/inmunología , Fragmentos de Péptidos/farmacología , Toxina Tetánica/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...